InsidersTradesSigma
Track the ST景峰 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST景峰 has logged 4 insider filings. Market capitalisation: €10.8bn. The latest transaction was filed on 12 September 2023 (Purchase). Among the most active insiders: 叶湘武. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST景峰是一家医疗保健和制药领域的公司，在XSHE市场上市。它专注于药品的开发和生产。